FDA clears the new T65 Coil with Integrated MT Determination Function

FDA clears the new T65 Coil with Integrated MT Determination Function

MagVenture announces the T65 Coil, the first release in the company’s upcoming T-series—a new generation of lighter, high-performance cooled coils. The FDA has cleared this coil in the US market.

Engineered with ergonomic design and active cooling, the T65 combines the features of both the C-B60 and Cool-B65 coils, making it suitable for both motor threshold measurements and treatment. It delivers approximately 50% more pulses than the Cool-B65 and it is developed to support operator comfort and efficient workflow.

Media inquiries:

Kerry Rome kr@magventure.com or Lauren Schultheiss ls@magventure.com, MagVenture, Inc., +1.888.624.7764

This news refers to FDA-cleared indications for use in the United States only. The products are not CE-marked and are not available for sale or clinical use in the European Union or other markets outside the US.